Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer

Hirofumi Kawakubo1, Jennifer L Carey, Elena Brachtel

  • 1Department of Surgical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

Oncogene
|September 21, 2004
PubMed

Insights

BTG2, an antiproliferative gene, is suppressed by hormones during pregnancy and in breast cancer. Loss of BTG2 is an early event in mammary tumor development, suggesting its role in cancer prevention.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • BTG2 is a p53-inducible gene with antiproliferative functions.
  • NF-kappaB activation stimulates BTG2 in breast cancer cells.
  • Hormonal regulation of BTG2 in mammary gland development is suggested.

Purpose of the Study:

  • To investigate the role of BTG2 in mammary gland development and breast cancer.
  • To explore the relationship between BTG2, hormones, and cell cycle regulators.
  • To assess BTG2 expression in human breast tumors.

Main Methods:

  • Analysis of BTG2 expression in rat mammary glands during pregnancy and lactation.
  • Investigation of BTG2 regulation by estrogen and progestin.
  • Assessment of BTG2's effect on cell cycle progression and cyclin D1 expression.
  • Comparison of BTG2 levels in human breast cancer cell lines and tumors versus normal tissues.
  • Examination of BTG2 protein in a mouse mammary tumor model.

Main Results:

  • BTG2 expression decreased during pregnancy and lactation in rat mammary glands, correlating with increased cyclin D1.
  • Estrogen and progestin suppressed BTG2 expression and stimulated cyclin D1.
  • Ectopic BTG2 expression inhibited breast cancer cell growth by causing G1 arrest, which was reversed by cyclin D1.
  • BTG2 was downregulated in human breast cancer cell lines and tumors.
  • Loss of BTG2 protein was observed early in mammary tumor development in mice.

Conclusions:

  • Hormonal downregulation of BTG2 may contribute to mammary gland proliferation during pregnancy.
  • BTG2 acts as a tumor suppressor by inhibiting cell proliferation and promoting G1 arrest.
  • Deregulation of BTG2 is an early event in mammary tumorigenesis and may be a critical step in breast cancer development.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...